SCHEMBL24379260

SCHEMBL24379260

CN(c1ccccc1Nc1nc(Cl)nc2ccsc12)S(C)(=O)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 3/20 0.41
▸ MET P08581 2/20 0.41
▸ BRAF P15056 1/20 0.39
▸ TNNI3K Q59H18 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ EGFR P00533 2/20 0.39
▸ PDE4B Q07343 2/20 0.38
▸ PDE7A Q13946 1/20 0.38
▸ PAK4 O96013 2/20 0.37
▸ PTK2 Q05397 2/20 0.37
▸ INSR P06213 1/20 0.37
▸ PIP4K2C Q8TBX8 1/20 0.37
▸ TYK2 P29597 3/20 0.37
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36
▸ TUBA4A P68366 1/20 0.36
▸ TUBB4B P68371 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19867182 0.81 ALK (0.46) ALKADORA2AADORA1PDE4BPDE7A
SCHEMBL24073814 0.77 BRAF (0.36) ALKBRAFTNNI3KADORA2AADORA1
SCHEMBL29709931 0.75 ALK (0.57) ALKMETEGFRPTK2INSR
SCHEMBL22518895 0.75 ALK (0.57) ALKMETEGFRPTK2INSR
SCHEMBL19867253 0.75 HTT (0.45) ADORA2AADORA1PDE4BPDE7APAK4
SCHEMBL29549332 0.74 ADORA2A (0.43) ADORA2AADORA1EGFRPDE4BPDE7A
SCHEMBL22828480 0.74 ADORA2A (0.43) ADORA2AADORA1EGFRPDE4BPDE7A
SCHEMBL25056236 0.74 ALK (0.46) ALKMETEGFRPTK2INSR
SCHEMBL600958 0.74 GLO1 (0.47) ALKMETEGFRPTK2INSR
SCHEMBL30950683 0.73 PIM1 (0.42) ADORA2AADORA1EGFRPDE4BPAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3988542-A1 PYRIMIDINE DERIVATIVE INHIBITING GROWTH OF CANCER CELL AND MEDICINAL USE THEREOF Oncobix Co.Ltd. (KR) 2022-04-27 — — EP disclosed
Send feedback